Australian oncology-focused biotech Kazia Therapeutics (Nasdaq: KZIA) has reported pre-clinical and translational data ...
Germany’s Merz Therapeutics today announced the appointment of Dan Staner as president, region Europe, effective 1. In this ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has started a review of Amgen’s Tavneos (avacopan), ...
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...
The Delhi High Court in India has upheld the grant of a pharmaceutical patent to privately-held Swiss drugmaker Helsinn ...
US pharma major Eli Lilly has announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh ...
Dutch biopharma company Pharming Group saw its shares tumble 13.5% to 1.48 euros this morning after it received a regulatory ...
Shares of US pharma Aquestive Therapeutics rocketed 45.4% to $4.20 this morning, despite receiving a Complete Response Letter ...
Australian radiopharmaceutical company AdvanCell has entered into a collaboration and exclusive licensing deal with Canadian ...
The European Medicines Agency’s human medicines committee (CHMP) issued multiple positive opinions on new medicines and ...
US genomics specialist Illumina (Nasdaq: ILMN) has completed its acquisition of proteomics company SomaLogic, adding large-scale protein analysis to its multiomics portfolio and strengthening its push ...
French pharma Sanofi (Euronext: SAN) says Phase III results for its oral candidate venglustat improved neurological symptoms in people with type 3 Gaucher disease, a rare inherited disorder. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results